Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity

Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression

(2011) Xiulong Xu et al.   BMC CANCER

Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells

(2011) R. Bedel et al.   CANCER RESEARCH

Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases

(2010) Takashi MURAMATSU   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

NKG2D and its ligands

(2009) Peyman Obeidy et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Propionic Acid Secreted from Propionibacteria Induces NKG2D Ligand Expression on Human-Activated T Lymphocytes and Cancer Cells

(2009) L. Andresen et al.   JOURNAL OF IMMUNOLOGY

Midkine translocated to nucleoli and involved in carcinogenesis

(2009) Li-Cheng Dai   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

(2008) Kui Li et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy

(2008) Nadia Guerra et al.   IMMUNITY